Home News Moms who receive investigational RSV vaccine pass antibodies to infants back to News
minute read
Infants born to mothers who were immunized with an investigational vaccine against respiratory syncytial virus — or RSV — received antibodies across the placenta, with no “evident safety concerns,” results from a phase 2b trial showed.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
